Manufacturing News and Research

RSS

Manufacturing is the production of products across all industries, on a large-scale, using machinery.

Speed Queen partners with BCRF to support search for breast cancer cure

For over 100 years, Speed Queen has been committed to manufacturing best-in-class laundry equipment to make families' lives easier. Today, the brand is reinforcing its commitment to families by partnering with The Breast Cancer Research Foundation (BCRF) to support the search for a cure for breast cancer by donating a portion from the purchase of a limited-edition washer and dryer pair.

16 Sep 2013

New catalyst class uses halogen bridges for environmentally friendlier production

Ninety percent of all chemical products require catalysts in the course of their manufacture. They accelerate reactions and reduce the energy needed. Catalysts participate in reactions, but are not consumed. As a result one catalyst molecule can convert millions of substrate molecules, which explains the great economic value of catalysts.

13 Sep 2013

Columbia Labs Buys Molecular Profiles For $25M

...

12 Sep 2013

Astrazeneca Licenses Merck's Cancer Candidate MK-1775

...

11 Sep 2013

Developing Analytical Techniques for Biotherapeutics

News-Medical talks to Dr. Lewis about the development of analytical equipment for a new era of drug development that goes beyond small molecule synthesis.

From Malvern Panalytical 11 Sep 2013

Improved lung function in patients with moderate asthma severity observed with investigational Tiotropium

Boehringer Ingelheim will present a pooled analysis of new data from the Phase 3 UniTinA-asthma® program at the European Respiratory Society (ERS) Annual Congress 2013 in Barcelona. The data from the individual MezzoTinA-asthma® Phase 3 studies (NCT01340209 and NCT00565266), from which the pooled data are derived, show the addition of tiotropium delivered via the Respimat® inhaler to medium-dose maintenance inhaled corticosteroid (ICS) therapy (defined as 400-800 µg budesonide/day or equivalent) improved lung function and provided sustained bronchodilation over 24 hours in patients with moderate asthma and airflow limitation. Tiotropium is being investigated to determine the medicine’s efficacy in treating asthma patients and is not currently approved for this indication.

11 Sep 2013

Paragon Bioservices awarded 2013 CMO Leadership Award for Quality and Reliability

Paragon Bioservices, a contract manufacturing organization whose expertise is the process development and manufacturing of biopharmaceuticals, announced today that it has been awarded the 2013 CMO Leadership Award for Quality and Reliability.

10 Sep 2013

Patients with COPD show improvements in lung function with olodaterol

Data from the olodaterol Phase 3 clinical program, presented for the first time at the European Respiratory Society (ERS) Annual Congress 2013 in Barcelona, showed the addition of olodaterol 5 and 10 µg delivered once daily via the Respimat® inhaler provided improvements in lung function in patients with moderate to very severe chronic obstructive pulmonary disease (COPD).

10 Sep 2013

New method helps reconnect injured organs or build functional human tissues from ground up

A team of researchers at the Wyss Institute of Biologically Inspired Engineering at Harvard University has found a way to self-assemble complex structures out of bricks smaller than a grain of salt.

10 Sep 2013

Once-daily COPD portfolio data from Novartis presented at European Respiratory Society (ERS) Annual Congress

Novartis announced new analyses of data for once-daily Ultibro® Breezhaler® (investigational QVA149 - indacaterol 85 mcg/glycopyrronium 43 mcg delivered dose, equivalent to 110 mcg/50 mcg metered dose per capsule), which showed significant improvements in lung function, shortness of breath and health-related quality of life for chronic obstructive pulmonary disease (COPD) patients versus all comparators1,2. These data were part of 39 respiratory abstracts presented at the European Respiratory Society (ERS) Annual Congress in Barcelona, Spain.

9 Sep 2013

McNeil Recalls 200,000 bottles of Concentrated MOTRIN Infants Drops Original Berry Flavor 1/2 fl oz

McNeil Consumer Healthcare Division of McNEIL-PPC, Inc. ("McNeil") is voluntarily recalling at the retail level three lots, approximately 200,000 bottles, of Concentrated MOTRIN® Infants' Drops Original Berry Flavor 1/2 fl oz bottles distributed in the United States.

7 Sep 2013

PaxVax commences phase 3 clinical trial for single-dose oral cholera vaccine candidate

PaxVax Inc, which develops and commercializes innovative vaccines against infectious diseases in a socially responsible manner, today announced that it has commenced its Phase 3 clinical trial program for its single-dose oral cholera vaccine candidate, PXVX0200 (also known as CVD 103-HgR). Approximately 3,000 participants will be enrolled in this pivotal program, which is comprised of cholera challenge, safety, and immunogenicity studies.

7 Sep 2013

Sanofi To Commercialize Pozen Proton Pump Inhibitor/Aspirin Product

...

6 Sep 2013

Capsugel Nabs Bend Research

...

5 Sep 2013

Sanofi To Commercialize Pozen Proton Pump Inhibitor/Aspirin Product

...

5 Sep 2013

Patheon's Q3 2013 revenues increase 30.4% to $265.7 million

Patheon Inc., a leading provider of contract development and commercial manufacturing services to the global pharmaceutical industry, with recently acquired proprietary products, announced today fiscal 2013 third quarter results.

5 Sep 2013

Sanofi, POZEN ink license agreement to commercialize PA8140 and PA32540 tablets in US

Sanofi US and POZEN Inc. announced the signing of an exclusive license agreement for the commercialization of POZEN's proprietary, investigational, coordinated-delivery tablets combining immediate-release omeprazole, a proton pump inhibitor, and enteric-coated aspirin in a single tablet ("PA"), PA8140 and PA32540.

5 Sep 2013

Manufacturing News and Research

Further Reading

Speed Queen partners with BCRF to support search for breast cancer cure

New catalyst class uses halogen bridges for environmentally friendlier production

Columbia Labs Buys Molecular Profiles For $25M

Astrazeneca Licenses Merck's Cancer Candidate MK-1775

Developing Analytical Techniques for Biotherapeutics

Improved lung function in patients with moderate asthma severity observed with investigational Tiotropium

Paragon Bioservices awarded 2013 CMO Leadership Award for Quality and Reliability

Patients with COPD show improvements in lung function with olodaterol

New method helps reconnect injured organs or build functional human tissues from ground up

Once-daily COPD portfolio data from Novartis presented at European Respiratory Society (ERS) Annual Congress

McNeil Recalls 200,000 bottles of Concentrated MOTRIN Infants Drops Original Berry Flavor 1/2 fl oz

PaxVax commences phase 3 clinical trial for single-dose oral cholera vaccine candidate

Sanofi To Commercialize Pozen Proton Pump Inhibitor/Aspirin Product

Capsugel Nabs Bend Research

Sanofi To Commercialize Pozen Proton Pump Inhibitor/Aspirin Product

Patheon's Q3 2013 revenues increase 30.4% to $265.7 million

Sanofi, POZEN ink license agreement to commercialize PA8140 and PA32540 tablets in US

Dakota Laboratories banned from manufacturing and distributing drugs

Cangene Signs Up To $77M Contract Extension With CDC

Cangene Inks Up To $77M Contract Extension With CDC

Exploring the G:Box and for high-quality imaging

Shaping the Future of Neuroscience: A Conversation with Atlas Antibodies on the MolBoolean™ and the Impact of SfN 2024

How the Arts Reshape Brain Function: Susan Magsamen on the Future of Neuroaesthetics

Latest Life Science News